Brian Farley has over 35 years of experience in the medical device and healthcare industry. In addition to his role as a board member at EndoStim, Mr. Farley currently sits on the board of three medical device companies serving as Chairman of both Myoscience Inc. and Neuronetics Inc. (NASDAQ: STIM) and serves as a director of Neurolutions Inc.

Recently, Mr. Farley served as Chairman of the Board of Entellus Medical, Inc. and also served as the company’s Chief Executive Officer from 2010 to 2015, leading the company in a successful IPO in early 2015. In February 2018, Stryker Corporation completed an acquisition of Entellus Medical. Prior to joining Entellus, Mr. Farley was President and CEO of VNUS Medical Technologies, Inc. He joined VNUS in 1995 as the first employee and led the company to become the market leader in the minimally invasive treatment of venous insufficiency. Mr. Farley led VNUS in a successful IPO in 2004 and in June 2009, VNUS was sold to Covidien. Prior to VNUS, Mr. Farley held various management and executive positions in research and development, clinical research and business development for Guidant Corporation, and in the medical division of Eli Lilly and Company. Mr. Farley holds both a B.S. in Engineering and an M.S. in Electrical Engineering with a Biomedical Engineering major from Purdue University.

Brian Farley

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.